Free Newsletter
Urology trial goes e-PRO
A large--but unnamed--drugmaker conducting a Phase II trial for a urology treatment will use electronic diaries to collect patient-reported outcome data. The 750-subject trial spans 22 countries on three continents and requires use of 34 languages, according to an announcement.
The sponsor selected the etrials eDiary 5.0 platform from Merge Healthcare. The manufacturer's eDiary Inventory Module, for tracking the shipping and supply of study data-capture devices, will also be used.
The eDiary 5.0 software, based on the Windows Mobile operating system, runs a ruggedized handheld device, the manufacturer says. Patients enter outcomes data using the device and then upload the data to a centralized electronic repository, where it is accessible to trial managers in real time.
- here's the announcement
Related Article:
Medidata plans Mass. blitz
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: